Webinar WG#4. Facing FDA's regulatory issues for targeted agents in oncology

As part of the Working Group #4 activities, we invite you to attend the next webinar of our Action that will be held on Thursday 8 December at 16h CET.

The webinar: Facing FDA's regulatory issues for targeted agents in oncology will be presented by Dr. Kay NOEL, a KOL with over 30 years’ experience in pharmaceutical development and 12 NDA approvals.

We wait for you!

European Cooperation in Science and Technology (COST) logo
EU flag logo

Funded by the Horizon 2020 Framework Programme
of the European Union